Clinical and Experimental Nephrology

, Volume 13, Issue 5, pp 447–451

Physicians make different decisions from nephrologists at serum creatinine 2.0 mg/dl

  • Kaichiro Tamba
  • Eiji Kusano
  • Kaoru Tabei
  • Eiji Kajii
  • Yasushi Asano
Original Article

Abstract

Background

It is very important, but not clear, how physicians differ from nephrologists in treatment of renal insufficiency.

Aim

To demonstrate differences in decision-making in treatment of renal insufficiency between physicians and nephrologists.

Design of study

Postal questionnaire.

Setting

All physicians were graduates from one medical school and certified by the Japanese Society of Internal Medicine. Nephrologists were certified by the Society and the Japanese Society of Nephrology.

Method

Questionnaires were sent to 1,395 physicians and 385 nephrologists, including audit of serum creatinine concentration that would indicate referral to nephrologist, audit of continuation of angiotensin converting enzyme inhibitor (ACEI) for a case of renal insufficiency and mild hyperkalemia due to ACEI. Outputs were proportion that selected “serum creatinine 177 μmol/l (2.0 mg/dl) and over” as a referral point to the nephrologist, and proportion that chose “suspend ACEI” for a case of renal insufficiency and mild hyperkalemia due to ACEI.

Results

Six hundred and fourteen physicians replied (44%), and 111 certified in internal medicine were extracted from them. One hundred and eighty-six certified nephrologists replied (47%), and 114 certified in internal medicine were extracted. The proportion that chose “177 μmol/l” as a referral point to the nephrologist was 20% for physicians and 61% for nephrologists (P < 0.0001). An additional 17% of nephrologists recommended creatinine concentration below 177 μmol/l, whereas no such opinion was found among physicians. The proportion that chose “suspend ACEI” was 45% for physicians and 16% for nephrologists (P < 0.0001).

Conclusion

There is significant difference between decisions made by physicians and nephrologists regarding treatment for patients with serum creatinine concentration of 177 μmol/l.

Keywords

General physician Nephrologist Serum creatinine Chronic kidney failure 

References

  1. 1.
    Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, et al. An overview of dialysis treatment in Japan (as of Dec. 31, 2007). J Jap Soc Dial Ther. 2009;42:1–45.CrossRefGoogle Scholar
  2. 2.
    Winkelmayer WC, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14:486–92.PubMedCrossRefGoogle Scholar
  3. 3.
    Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31:398–417.PubMedCrossRefGoogle Scholar
  4. 4.
    Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis. 1998;32:278–83.PubMedCrossRefGoogle Scholar
  5. 5.
    National Kidney Foundation. K/DOQI, clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1–266.Google Scholar
  6. 6.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant. 1995;10:1963–74.PubMedGoogle Scholar
  8. 8.
    Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 1996;334:939–45.PubMedCrossRefGoogle Scholar
  9. 9.
    Japanese Society for Nephrology (2007). Clinical practice guidebook for diagnosis and treatment of chronic kidney disease. Tokyo-igakusha.Google Scholar
  10. 10.
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Kalra PA, Kumwenda M, MacDowall P, Roland MO. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ. 1999;318:234–7.PubMedGoogle Scholar
  12. 12.
    de Lusignan S, Chan T, Stevens P, O’Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22:234–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med. 2004;164:1788–92.PubMedCrossRefGoogle Scholar
  14. 14.
    Tian S, Kusano E, Ohara T, Tabei K, Itoh Y, Kawai T, et al. Cystatin C measurement and its practical use in the patients with various renal diseases. Clin Nephrol. 1997;48:104–8.PubMedGoogle Scholar
  15. 15.
    Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79–83.PubMedGoogle Scholar
  16. 16.
    Ichihara K, Saito K, Itoh Y. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population. Clin Chem Lab Med. 2007;45:1232–6.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2009

Authors and Affiliations

  • Kaichiro Tamba
    • 1
  • Eiji Kusano
    • 2
  • Kaoru Tabei
    • 3
  • Eiji Kajii
    • 1
  • Yasushi Asano
    • 2
  1. 1.Department of General Practice, School of MedicineJichi Medical UniversityShimotsukeJapan
  2. 2.Division of Nephrology, Department of Internal Medicine, School of MedicineJichi Medical UniversityShimotsukeJapan
  3. 3.Jichi Medical University Saitama Medical CenterSaitamaJapan

Personalised recommendations